Compliance Blog
Twenty-Fourth Annual Pharmaceutical & Medical Device Ethics & Compliance Conference
DOJ's recent policy changes on Self-Disclosure present new challenges for legal and compliance professionals. If you want to learn more about them, please join us for what we believe will be a...
HCCA Complete Healthcare Compliance Manual
The 2023 version is now available. The Complete Healthcare Compliance Manual is an all-in-one, comprehensive guide that provides new and experienced compliance practitioners with guidance and...
Moving the Needle – It’s Time to Rethink the Ethics & Compliance Dialog
Thirty years have passed since ethics and compliance were added to the working vocabulary of life sciences. I know because I was there at the beginning. However, while the business of healthcare...
The Opioid Crisis & the Risk of Diversion
HCCA has just published an updated version of its Complete Healthcare Compliance Manual for 2022. The Complete Healthcare Compliance Manual is an all-in-one, comprehensive guide that provides new...
Mitchell Hamline & MSBA Host CLE Program Tackling the Theranos Case
This CLE program is a collaboration between Mitchell Hamline's Health Law Institute and the Health Law Section of the Minnesota State Bar Association. Dr. Whitelaw and Manny Tzavlakis, Managing...
History of Health Care Compliance – HCCA Podcast
I recently chatted with Adam Turteltaub about the history of health care compliance. Adam is HCCA's Chief Engagement & Strategy Officer. Click the link to check out the podcast: Seth Whitelaw...
Mitchell Hamline Health Law Institute Highlights
So far 2020 has been a great year for Mitchell Hamline's Health Law Institute! Check it out [button link="https://mitchellhamline.edu/health-law-institute/intro/highlights-2020/" color="green"...
Health Care Law & Opioids: How the “Man-Made Plague” Is Transforming the Pharmaceutical Industry (4064)
The current opioid epidemic has been branded as “the worst drug crisis in America’s history” and a “man-made plague.” According to the Centers for Disease Control and Prevention (“CDC”), the current...
Managing Compliance Remotely – Responding to COVID-19
On Monday, April 13, 2020, I will be joining an elite group of fellow panelists to discuss the opportunities and challenges of managing a pharmaceutical or medical device compliance function...